(Q63397798)
Statements
A Randomized, Double-Blind, Placebo-Controlled Efficacy Study of The Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic Dermatitis (English)
0 references
30 June 2018
0 references
December 2019
0 references
500
0 references
18 year
0 references
70 year
0 references